We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Medicines Agency is providing guidance on how drugmakers can best incorporate patient-reported outcomes in developing oncology studies. Read More
In a change of heart from earlier draft guidance, the UK’s National Institute for Health and Care Excellence has recommended reimbursement for Sanofi’s Jevtana for treating prostate cancer. Read More
The FDA is providing updated guidance on assessing the effects of protein-based treatments on the immune system, providing advice on how to validate results but little new information on testing protocols. Read More
Heparin is back in the news, after France’s National Agency for Medicines and Health Products Safety issued a GMP noncompliance statement to China’s Dongying Tiandong Pharmaceutical, which manufactures the active ingredients of Lovenox and Heparin. Read More